Your browser doesn't support javascript.
loading
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
Horbinski, Craig; Nabors, Louis Burt; Portnow, Jana; Baehring, Joachim; Bhatia, Ankush; Bloch, Orin; Brem, Steven; Butowski, Nicholas; Cannon, Donald M; Chao, Samuel; Chheda, Milan G; Fabiano, Andrew J; Forsyth, Peter; Gigilio, Pierre; Hattangadi-Gluth, Jona; Holdhoff, Matthias; Junck, Larry; Kaley, Thomas; Merrell, Ryan; Mrugala, Maciej M; Nagpal, Seema; Nedzi, Lucien A; Nevel, Kathryn; Nghiemphu, Phioanh L; Parney, Ian; Patel, Toral R; Peters, Katherine; Puduvalli, Vinay K; Rockhill, Jason; Rusthoven, Chad; Shonka, Nicole; Swinnen, Lode J; Weiss, Stephanie; Wen, Patrick Yung; Willmarth, Nicole E; Bergman, Mary Anne; Darlow, Susan.
Afiliación
  • Horbinski C; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Nabors LB; O'Neal Comprehensive Cancer Center at UAB.
  • Portnow J; City of Hope National Medical Center.
  • Baehring J; Yale Cancer Center/Smilow Cancer Hospital.
  • Bhatia A; University of Wisconsin Carbone Cancer Center.
  • Bloch O; UC Davis Comprehensive Cancer Center.
  • Brem S; Abramson Cancer Center at the University of Pennsylvania.
  • Butowski N; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Cannon DM; Huntsman Cancer Institute at the University of Utah.
  • Chao S; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Chheda MG; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Fabiano AJ; Roswell Park Comprehensive Cancer Center.
  • Forsyth P; Moffitt Cancer Center.
  • Gigilio P; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Hattangadi-Gluth J; UC San Diego Moores Cancer Center.
  • Holdhoff M; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Junck L; University of Michigan Rogel Cancer Center.
  • Kaley T; Memorial Sloan Kettering Cancer Center.
  • Merrell R; Vanderbilt-Ingram Cancer Center.
  • Mrugala MM; Mayo Clinic Cancer Center.
  • Nagpal S; Stanford Cancer Institute.
  • Nedzi LA; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
  • Nevel K; Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
  • Nghiemphu PL; UCLA Jonsson Comprehensive Cancer Center.
  • Parney I; Mayo Clinic Cancer Center.
  • Patel TR; UT Southwestern Simmons Comprehensive Cancer Center.
  • Peters K; Duke Cancer Institute.
  • Puduvalli VK; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Rockhill J; Fred Hutchinson Cancer Center.
  • Rusthoven C; University of Colorado Cancer Center.
  • Shonka N; Fred and Pamela Buffet Cancer Center.
  • Swinnen LJ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Weiss S; Fox Chase Cancer Center.
  • Wen PY; Dana-Farber Cancer Institute.
  • Willmarth NE; American Brain Tumor Association.
  • Bergman MA; National Comprehensive Cancer Network.
  • Darlow S; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 21(1): 12-20, 2023 01.
Article en En | MEDLINE | ID: mdl-36634606
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of the following adult CNS cancers: glioma (WHO grade 1, WHO grade 2-3 oligodendroglioma [1p19q codeleted, IDH-mutant], WHO grade 2-4 IDH-mutant astrocytoma, WHO grade 4 glioblastoma), intracranial and spinal ependymomas, medulloblastoma, limited and extensive brain metastases, leptomeningeal metastases, non-AIDS-related primary CNS lymphomas, metastatic spine tumors, meningiomas, and primary spinal cord tumors. The information contained in the algorithms and principles of management sections in the NCCN Guidelines for CNS Cancers are designed to help clinicians navigate through the complex management of patients with CNS tumors. Several important principles guide surgical management and treatment with radiotherapy and systemic therapy for adults with brain tumors. The NCCN CNS Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding molecular profiling of gliomas.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias del Sistema Nervioso Central Tipo de estudio: Diagnostic_studies / Guideline Límite: Adult / Humans Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias del Sistema Nervioso Central Tipo de estudio: Diagnostic_studies / Guideline Límite: Adult / Humans Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos